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Abstract: The aim of this study was to identify and evaluate the chemical compositions and effects of
the S. tuberosa leaf and root hydroalcoholic extracts (HELST and HERST) against different strains of
Candida. Chemical analysis was performed by Ultra-Performance Liquid Chromatography Coupled
to Quadrupole/Time of Flight System (UPLC-MS-ESI-QTOF). The Inhibitory Concentration of 50%
of the growth (IC50) as well as the intrinsic and combined action of the extracts with the antifungal
fluconazole (FCZ) were determined by the microdilution method while the minimum fungicidal
concentrations (MFCs) and the effect on fungal morphological transitions were analyzed by subculture
and in humid chambers, respectively. From the preliminary phytochemical analysis, the phenols
and flavonoids were the most abundant. The intrinsic IC50 values for HELST ranged from 5716.3
to 7805.8 µg/mL and from 6175.4 to 51070.9 µg/mL for the HERST, whereas the combination of the
extracts with fluconazole presented IC50 values from 2.65 to 278.41 µg/mL. The MFC of the extracts,
individually, for all the tested strains was ≥16384 µg/mL. When fluconazole was combined with
each extract, the MFC against CA URM 5974 was reduced (HELST: 2048 and HERST: 4096 µg/mL).
Synergism was observed against standard C. albicans (CA) and C. tropicalis (CT) strains and with the
root extract against the CT isolate. The leaf extract inhibited the morphological transition of all strains
while the root extract inhibited only CT strains.
Keywords: chromatography; fluconazole; Candida spp., morphological transition
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1. Introduction
Candida species, especially C. albicans, are commonly found on human mucosal surfaces but
are becoming an important progressive invasive pathogen due to their increased prevalence in
immunocompromised patients and the increased use of antibiotics [1].
Infections caused by the Candida genus are associated with a high morbidity and mortality rate,
where these species are responsible for superficial and systemic candidiasis, with the latter being a
serious problem for health systems and patients [2]. Several Candida species are polymorphic and able
to transition between different morphological conditions involving yeast, hyphal, and pseudohyphal
forms [3].
The inappropriate use of antifungal drugs contributes to the increase in microbial resistance,
thus an understanding the mechanisms of antifungal drugs, the cellular molecular mechanisms
involved in the antifungal resistance process, is sought [4]. Given the few commercially available
antifungals and their varied side effects, a need to produce new and more effective antifungal agents
with fewer adverse effects exists [5].
Studies addressing the use of plants have been growing in Brazil as well as worldwide, increasing
the importance and knowledge of their chemical components [6]. In this sense, natural products and
their chemical diversity are seen as options for potentially active therapeutic sources, which can be a
means of discovering new drugs [7].
Spondias tuberosa Arruda (umbu) is a native plant from Brazil, belonging to the Anacardiaceae
family, with great ecological and economic importance [8], being used in popular medicine for
infections, stomach disorders, and inflammatory conditions [9]. Among its biological activities,
its anti-inflammatory [10], anticancer [11], antibacterial [12], antioxidant [13], and antiviral activities
stand out [14].
Using ethnobiology as a guiding strategy for bioactivity research, the objective of this study was
to identify the chemical composition of the S. tuberosa leaf and root hydroalcoholic extracts and their
antifungal effect, both the intrinsic and combined effect with conventional fluconazole, as well as their
action on morphological transition, a Candida spp. virulence factor.
2. Results
The leaf and root extract yields were, respectively, 0.74% and 0.635%. Preliminary phytochemical
analysis of the extracts revealed the presence of several metabolite classes, such as: Alkaloids, steroids,
phenols, flavonoids, triterpenoids, and xanthones (Table 1). It is noteworthy that the presence of
phenols and flavonoids prevailed in all extracts. Among the secondary metabolites investigated,
coumarins, flavanonols, and tannins were not detected.
Table 1. Preliminary phytochemical analysis of extracts.
Special Metabolite Classes (SMC)
SMC 1 SMC 2 SMC 3 SMC 4 SCM 5 SMC 6 SMC 7 SMC 8 SMC 9 SMC 10
HELST + - + - - + - + - +
HERST + - - + - + - - + -
SMC 1: Phenols; SMC 2: Tannins; SMC 3: Flavonoids of the flavone, flavonol and xanthone type; SMC 4:
Flavonoids of the anthocyanin and anthocyanidin type; SMC 5: Flavanoid of leucoanthocyanidins, catechins; SMC 6:
Flavanone-type flavanoid; SMC 7: Flavanoid Flavanoid; SMC 8: Steroids; SMC 9: Triterpenoids; SMC 10: Alkaloids;
(+): positive; (-): absent.
In UPLC-MS-ESI-QTOF, identification of the compounds was based on their molecular ion mass,
retention time, fragmentation pattern, and data available in the literature, as shown in Tables 2 and 3,
according to the order of elution, molecular formula, error, and major fragments (MS2).
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Table 2. Ultra-Performance Liquid Chromatography Coupled to Quadrupole/Time of Flight System
(UPLC-MS-ESI-QTOF) identification of hydroalcoholic extract compounds of Spondias tuberora leaves.
Peak no. Rt min [M-H]
-
Observed
[M-H]-
Calculated
Product Ions
(MS/MS)
Empirical
Formula
Ppm
(error) Putative Name References
1 2.82 174.9525 174.9502 175.9599 C6H6O6
Dehydroascorbic
acid [15]
2 3.28 443.1294 443.1283
381.1805,
281.1358,
119.0361
C21H32O10 2.5
Dehydrophaseic
acid hexose [16]
3 3.40 189.0021 189.0035
207,0115,
188.9965,
126.9987
C6H5O7 −7.4 None identified -
4 3.65 188.9986 188.9977
207.0199,
188.9996,
127.0019
C13HO2 4.8 None identified -
5 4.53 191.0109 191.0133 173.0243,127.0278, 85.0283 C7H12O6 −12.6
Quinic acid
(Organic acid) [17,18]
6 4.65 343.0833 343.0818
191.0497,
169.0125,
125.0265
C14H16O10 4.4
Galloyl quinic
acid isomer Ia [18]
7 4.67 343.0508 343.0513
191.0523,
169.0112,
125.0259
C14H16O10 −1.5 Galloyl quinicacid isomer IIa [18]
8 4.74 343.1045 343.1029
191.0196,
169.0011,
125.9942
C14H16O10 4.9
Galloyl quinic
acid isomer III [18])
9 4.89 343.0904 343.0877
191.0540,
169.0121,
125.0247
C14H16O10 7.9
Galloyl quinic
acid isomer IV [18]
10 6.28 421.2582 421.2590 331.0801,3010357 C19H18O11 −1.9 Mangiferin [15,19]
11 6.48 939.4997 939.4989
787.4410,
277.2166,
125.0243
C41H32O26 0.9
Penta-O-galloyl
hexoside [20]
12 6.56 397.1313 397.1287
502.2910,
474.2616,
277.2155
C22H21O7 6.5 None identified -
13 6.90 277.2142 277.2168
279.2315,
277.2151,
189.0038
C18H29O2 −9.4 None identified -
14 7.00 339.2007 339.2019 - C22H28O3 −3.5 Caffeoyl-D-glucose [16]
15 7.50 483.2540 483.2535
271.0134,
169.0511,
125.9984
C20H20O14 1.0
Digalloyl
glucose
(Digalloyglucose)
[16,21]
[M-H]-—Reference Ion on negative ion mode.
Table 4 shows the IC50 values of the extracts, fluconazole, and their combined action, where the
concentration in which the natural product or the drug could reduce the microorganismal population
by 50% can be seen. The HESTL and HESTR values were not clinically significant while fluconazole
achieved a 50% reduction in the fungal population, whereas when associated with leaf extract, there was
an increase in drug action. With root extract, the effect was similar to fluconazole for C. albicans strains,
and for CT INCQS 40042, there was a decrease in the effect of the drug, while for CT URM there was
an improvement in fluconazole action.
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Table 3. UPLC-MS-ESI-QTOF identification of hydroalcoholic extract compounds of Spondias
tuberora roots.
Peak no. Rt min [M-H]
-
Observed
[M-H]-
Calculated
Product Ions
(MS/MS)
Empirical
Formula
Ppm
(error) Putative Name References
1 2.83 272.9554 272.9578
274.9536,
273.9563,
158.9753
C15H12O5 −8.8 (±)-Naringenin [15]
2 3.11 341.2104 341.2117
297.2246,
295.2048,
119.0465
C22H30O3 2.1 Anacardic acid 1 [16]
3 3.14 343.1186 343.1182 299.2344 C22H21O3 1.2 Anacardic acid 2 [16]
4 3.16 377.0822 377.0814
379.0782,
377.0770,
341.1009
C25H13O4 2.1 No identified -
5 3.22 345.0010 345.0035 301.2471 C22H34O3 −7.2 Anacardic acid 3 [16]
6 3.52 355.0232 355.0243 355.0258,163.0371 C16H18O9 −3.1 Chlorogenic acid [9]
7 4.39 411.0173 411.0213
411.0232,
240.9987,
169.0123
C17H7N4O9 −9.7 None identified -
8 4.50 461.1219 461.1236
257.0848,
229.8624,
151.0033
C22H21O11 −3.7 Kaempferol-7-Oglucuronide [16]
9 4.62 197.0424 197.0450 199.06, 198.05,182.0187 C9H10O5 −13.2
2-Hydroxy-3,4-
dimethoxybenzoic acid [15]
10 4.90 433.0583 433.0560 300.9944,271.0716 C20H18O11 5.3 Quercetin O-pentoside [20]
11 4.99 315.0096 315.0082
394.9633,
315.0095,
299.9882
C16H12O7 4.4 Rhamnetin [22]
12 5.05 463.1048 463.1029 316.0255,271.0625 C21H20O12 4.1 Myricetin O-deoxyhexoside [20]
13 5.08 449.1247 449.1236 316.0205 C20H18O12 2.4 Myricetin O-pentoside [20]
14 5.35 331.2458 331.2484
271.0428,
241.0313,
125.0252
C9H16O13 −7.8 Monogalloyl-glucose [16]
15 5.52 461.2616 461.2598 315.0131 C21H17O12 3.9 Isorhamnetin Orhamnoside [23]
16 6.15 833.5256 833.5262
833.5175,
507.2970,
175.0390
C43H77O15 0.7 None identified -
[M-H]-—Reference Ion on negative ion mode.
Table 4. 50% inhibitory concentration (IC50) of microorganisms (µg/mL) by extracts, fluconazole, and
their combination.
CA INCQS 40006 CA URM 5974 CT INCQS 40042 CT URM 4262
HELST 6211.1 * 5716.3 * 7166.8 * 7805.8 *
HERST 6264.8 * 8919.9 * 51070.9 * 6175.4 *
FLUCONAZOLE 22.79 3.97 88.08 47.30
HELST + FCZ 13.60 2.65 * 44.86 * 43.75
HERST + FCZ 25.81 4.38 278.41 * 26.15 *
CA: Candida albicans; CT: Candida tropicalis; INCQS: National Institute of Quality Control in Health; URM: University
Recife Mycology; HELST: Hydroalcoolic Extract of Leaves Spondias tuberosa; HERST: Hydroalcoholic Extract of the
Roots of Spondias tuberosa; FCZ: Fluconazole. * Corresponding to the ANOVA with p < 0.0001 for all data.
The action of the extracts and fluconazole on the cell viability curve can be seen in Figure 1.
The extracts presented no relevant action against the tested strains while fluconazole presented a more
effective action against CA URM 5974 (32 µg/mL), and against other strains when its concentration
was increased.
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In the antivirulence assay, the HELST was able to inhibit hyphal emission at the highest 
concentration (HCE) in all tested strains. At the HCE/4 concentration, the extract reduced 
morphological transition by 44.09% and 45.45%, respectively, against CA INCQS 40006 and CT 
INCQS 40042 when compared to the growth control. At lower concentrations, the HELST presented 
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and CT URM 4262 while it reduced hyphal growth by 54.30% and 62.09% respectively, for CA INCQS 
40006 and CA URM 5974, all relative to the growth control. At the lowest concentrations, the HERST 
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Figure 4 shows the filamentous structures in the growth control and the progressive effect of 
fluconazole and HELST on C. tropicalis yeast morphology (CT INCQS 40042). The micromorphology 
recordings for fluconazole presented inhibition at all tested concentrations while the HELST caused 
inhibition at the HCE concentration (8192 µg/mL) and a decrease in hyphae and pseudohyphae 
growth at the HCE/4 concentration (2048 µg/mL). The HCE/16 concentration (512 µg/mL) presented 
similar results to the growth control. 
Generally, the HELST obtained better results in all the performed tests, which is interesting from 
the point of view of the conservation of the species, as since the leaves are more accessible, the 
collection is practical and less harmful to the plant. 
 
Figure 1. Cell viability curve demonstrating the inhibitory effect of fluconazole and hydroalcoholic 
extracts of Spondias tuberosa against Candida strains. CA: Candida albicans; CT: Candida tropicalis; 
INCQS: National Institute of Quality Control in Health; URM: University Recife Mycology; HELST: 
Hydroalcoholic Extract of Leaves of Spondias tuberosa; HERST: Hydroalcoholic Extract of the Roots of 
Spondias tuberosa; FCZ: Fluconazole. ****—Statistical significance with p < 0.0001. 
i r . ll i ilit r tr ti t i i it r ff t f fl l r l li
e tr cts f o ias t berosa i st a i a str i s. CA: Candida albicans; CT: andida tro icalis;
I S: ati al I stit te f alit tr l i ealt ; : i ersity ecife cology; ELST:
ydroalcoholic Extract of Leaves of Spondias tuberosa; E ST: ydroalcoholic Extract of the oots of
Spondias tuberosa; F Z: Fluconazole. **** Statistical significance ith p < 0.0001.
The MFC of the extracts against all tested strains was ≥16,384 µg/mL, as well as the fluconazole
MFC against C. tropicalis, thus observing a fungistatic effect. The FCZ effect was termed fungicidal at a
concentration of 8192 µg/mL (Table 5) against standard and isolated C. albicans strains. An MFC of 2048
and 4096 µg/mL, respectively, was observed against the CA isolate in the fluconazole combination
with the HELST and HERST extracts while the MFC ranged from 8192 to ≥16,384 µg/mL against the
other tested strains.
Table 5. Minimal fungicidal concentration (MFC) of microorganisms (µg/mL) by extracts, fluconazole,
and their combination.
CA INCQS 40006 CA URM 5974 CT INCQS 40042 CT URM 4262
HELST ≥16,384 ≥16,384 ≥16,384 ≥16,384
HERST ≥16,384 ≥16,384 ≥16,384 ≥16,384
FLUCONAZOLE 8192 8192 ≥16,384 ≥16,384
HELST + FCZ 8192 2048 ≥16,384 8192
HERST + FCZ 8192 4096 ≥16,384 ≥16,384
CA: Candida albicans; CT: Candida tropicalis; INCQS: National Institute of Quality Control in Health; URM: University
Recife Mycology; HELST: Hydroalcoolic Extract of Leaves Spondias tuberosa; HERST: Hydroalcoholic Extract of the
Roots of Spondias tuberosa; FCZ: Fluconazole.
When combined with the antifungal agent fluconazole, the HELST potentiated the effect of the
drug, where a synergistic effect against CA INCQS 40006 (8 to 256 µg/mL) and CT INCQS 40042 (8 to
512 µg/mL) was observed. On the other hand, the cell viability curve for CA URM 5974 and CT URM
4262 isolates was similar to that of fluconazole (Figure 2).
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A synergism against CA INCQS 40006 (64 to 1024 µg/mL), CA URM 5974 (16 µg/mL), and CT
URM 4262 (8 to 1024 µg/mL) can be observed when the HERST was combined with fluconazole.
However, an antagonism was observed against the standard CT INCQS 40042 strain (16 to 256 µg/mL),
where the combination with the extract diminished the effect of the drug.
In the antivirulence assay, the HELST was able to inhibit hyphal emission at the highest
concentration (HCE) in all tested strains. At the HCE/4 concentration, the extract reduced morphological
transition by 44.09% and 45.45%, respectively, against CA INCQS 40006 and CT INCQS 40042 when
compared to the growth control. At lower concentrations, the HELST presented insignificant or similar
results to the growth control. Fluconazole inhibited the tested strains at all concentrations (Figure 3).
The HERST caused filament inhibition only at the highest concentration for CT INCQS 40042 and
CT URM 4262 while it reduced hyphal growth by 54.30% and 62.09% respectively, for CA INCQS
40006 and CA URM 5974, all relative to the growth control. At the lowest concentrations, the HERST
did not obtain considerable results.
Figure 4 shows the filamentous structures in the growth control and the progressive effect of
fluconazole and HELST on C. tropicalis yeast morphology (CT INCQS 40042). The micromorphology
recordings for fluconazole presented inhibition at all tested concentrations while the HELST caused
inhibition at the HCE concentration (8192 µg/mL) and a decrease in hyphae and pseudohyphae growth
at the HCE/4 concentration (2048 µg/mL). The HCE/16 concentration (512 µg/mL) presented similar
results to the growth control.
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Figure 4. Demonstrative effect of HELST and fluconazole on the morphological transition of Candida
tropicalis. CT: Candida tropicalis; INCQS: National Institute of Quality Control in Health; URM: University
Recife Mycology; HELST: Hydroalcoholic Extract of Leaves of Spondias tuberosa; FCZ: Fluconazole;
HCE: Higher Concentration Evaluate; a: presence of filamentous structures; b: absence of filamentous
structures. A—hyphae development; B—hyphae inhibition.
Generally, the HELST obtained better results in all the performed tests, which is interesting from
the point of view of the conservation of the species, as since the leaves are more accessible, the collection
is practical and less harmful to the plant.
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3. Discussion
Phytochemical studies using the S. tuberosa leaf methanolic and ethyl acetate extracts also revealed
the presence of phenols, flavonoids, flavones, triterpenes, and steroid compounds, similar to those
found in the present study analysis; however, these also found cinnamic derivatives, saponins, and
leucoanthocyanidins, which differ from the present results [14,24]. The S. monbin ethanolic extract
revealed the presence of polyphenols and flavonoids [25]. The authors of [9] found chlorogenic acid in
S. tuberosa leaf hydroethanolic extract by HPLC analysis, with the same compound being identified in
the root hydroalcoholic extract of the same species.
The authors of [26] inhibited C. albicans growth with S. tuberosa leaf hexanic extract using a different
methodology, obtaining an IC50 of 2.0 mg/mL, a result that is different to those of the present study;
however, the authors did not detect a fungicidal effect, a result similar to that of this study. S. tuberosa
bark ethanolic extract did not inhibit growth of the C. albicans, C. glabrata, C. krusei, or C. tropicalis
strains with the disc diffusion technique [27], whose effect may be explained by the fact that the hexane
extract have a lower polarity and the extracted constituents are different from those obtained with the
extracts in this study [28].
Some of the compounds identified in the S. tuberosa leaf and root extracts are reported in the
literature for their antifungal activity. The author of [29] reports the antifungal activity of mangiferin.
An inhibition in filament growth was observed with the C. albicans (ATCC 90028 and MTCC 186) strains
and clinical isolates (CA1, CA2, CA3, and CA4) in a study addressing the synergistic association of
quinic acid with undecanoic acid on Candida spp. morphological transition. However, only a moderate
inhibition was observed for C. tropicalis (MTCC 184) strains and isolates (CT1, CT2, and CT3) [30].
The authors of [31] tested several compounds using the disc diffusion method where one of them was
narigenin, a compound present in HERST, which demonstrated activity against C. albicans.
The authors of [30] showed that quinic acid, which was identified in the HELST, did not inhibit the
growth of Candida strains at varying concentrations (12.5–800 µg mL−1). In a study on the antifungal
activity of chlorogenic acid, the yeasts Trichosporon beigelii (KCTC 7707), Malassezia furfur (KCTC 7744),
and C. albicans (TIMM 1768) were susceptible to the compound, with MIC values between 40 and 80
µg/mL [32]. Chlorogenic acid achieved a partial reduction in the mycelial growth of some pathogenic
plant fungi [33]. The chlorogenic acid effect on C. albicans dimorphism was investigated, where this was
able to inhibit and destroy hyphae. The authors attribute the action of this compound, which affects
yeast cells, to it damaging their membranes and disrupting their membrane potential [32].
The use of different Spondias monbin L. parts in combination with fluconazole inhibited the growth
of C. albicans ATCC 90029 and C. krusei, where the author associated this result with the compounds
present in the plant, which may have increased the effect of the drug [34]. The S. monbin leaf extract
inhibited the Saccharomyces cerevisiae NCPF 3178 yeast strain (7 to 7.5 mm) in the disk diffusion
method and presented a minimum inhibitory concentration (MIC) of 250 µg/mL [35] by microdilution.
The authors of [25] tested S. monbin ethanolic extract against C. albicans ATCC 10231, C. guilliermondii
ATCC 6260 and C. krusei ATCC 34135 using a similar technique to that applied in this study, obtaining
MIC values >1000 µg/mL−1.
Other species that are also from the Anacardiaceae family have been investigated for their activity
against fungi. A study with Anacardium occidentale L. and Mangifera indica L. leaves against C. albicans
obtained an MIC of 1250 µg/mL and MFC of 1250 and 2500 µg/mL, respectively [36]. The A. occidentale
ethanolic extract from the plant’s flowers, leaves, and stem bark were investigated using the disc
diffusion technique, where the flower extract inhibited different C. albicans and C. tropicalis (1 mm)
strains, while the leaf and stem bark extracts inhibited C. albicans 37 (1 mm) and fluconazole inhibited
the C. albicans and C. tropicalis strains (1 to 2 mm) [37].
The diversity of chemical classes that are present in an extract are defined as complex heterogeneous
mixtures, each of which has different biological or pharmacological activities and collectively contribute
to the bioactivity of the extract as a whole [38,39], thus the moderate activity demonstrated by the
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S. tuberosa leaf and root hydroalcoholic extracts against species from the Candida genus may have
occurred due to the synergistic action of the chemical constituents present in the extracts.
4. Materials and Methods
4.1. Botanical Material Collection and Identification
The botanical material was collected with consent from the Biodiversity Authorization and
Information System SISBIO-number 64293-1, in the community of Lameiro (07◦, 15′03.1′′ S and 39◦,
23′48.3′′ W of Greenwich), in the municipality of Crato, southern Ceará, Brazil. Specimens from
seven individuals were collected from 8:00 to 9:30 in the morning. A sample of the collected material
was deposited in the Herbarium Dárdano de Andrade Lima (HCDAL) of the Regional University of
Cariri-URCA with the herbarium number 13.728, identified by Professor Ana Cleide Alcantara Morais
Mendonça as being the species Spondias tuberosa Arruda.
4.2. Extract Acquisition
For the extract preparations, healthy young roots and leaves collected from the upper part of
the plant were used. The hydroalcoholic extract (tincture or alcohol) was prepared in 70% alcohol
(ethanol) at 500 g of fresh leaves or 400 g of dried root for every 2.652 L of alcohol/water proportion [40]
with modifications.
Extract drying was performed by spray drying using the Mini-spray dryer MSDi 1.0 (Labmaq
do Brasil) using a 1.2-mm spray nozzle under the following operating conditions: (a) Flow control:
500 mL/h; (b) inlet temperature: 130 ± 2 ◦C; (c) outlet temperature: 74 ± 2 ◦C; (d) atomization air flow:
45 L/min; and (e) blower flow: 1.95 m3/min. The spray drying process consists of a product that is in
the liquid state changing to a solid state in powder form by passing through a heated medium under
continuous operation [41].
4.3. Chemical Analysis
4.3.1. Preliminary Phytochemical Analysis
The extracts were subjected to preliminary phytochemical analysis based on qualitative methods
proposed by [42]. In these experiments, characterization of the main metabolite classes was performed
by chemical reactions, with the addition of specific reagents resulting in color changes and/or precipitate
formations characteristic of the following metabolite classes: Alkaloids, steroids, phenols, flavonoids,
tannins, and triterpenoids. All experiments were performed in triplicates and the secondary metabolite
classes present in the extracts were classified as present (+) or absent (-).
4.3.2. Compound Identification by Ultra-Performance Liquid Chromatography Coupled to
Quadrupole/Time of Flight System (UPLC-MS-ESI-QTOF)
Identification of the compounds present in the extracts was performed in an Acquity® UPLC
system coupled to a Quadrupole/Time of Flight (QTOF) system (Waters Corporation, Milford, MA,
USA), provided by the Chemical and Natural Products Laboratory, Embrapa Tropical Agroindustry
(Fortaleza, Ceará). Chromatographic runs were performed with a Waters Acquity® UPLC BEH column
(150 × 2.1 mm; 1.7 µm), a fixed temperature of 40 ◦C, mobile phases with 0.1% formic acid (A) and
acetonitrile with 0.1% formic acid (B), gradient ranging from 2% to 95% B (15 min), 0.4 mL/min flow
rate, and 5 µL injection volume. The ESI- mode was obtained in the 110–1180 Da range with a fixed
source temperature of 120 ◦C, 350 ◦C desolvation temperature, 500 L/h desolvation gas flow, 0.5 V
extraction cone, and 2.6 kV capillary voltage. Leucine encephalin was used as the lock mass. The MSE
(high energy mass spectrometry) acquisition mode was used. The instrument was controlled by the
Masslynx® 4.1 software (Waters Corporation, Milford, USA).
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4.4. Antifungal Assays
4.4.1. Microorganisms, Culture Media, Inoculum Preparation, and Drugs and Reagents Used
Two standard strains, Candida albicans-CA INCQS 40006 and Candida tropicalis-CT INCQS 40042,
obtained from the Oswaldo Cruz Culture Collection of the National Institute for Quality Control in
Health (INCQS) and two clinical isolates, Candida albicans-CA URM 5974 and Candida tropicalis-CT
URM 4262, provided by the Recife Micoteca University (URM) from the Federal University of
Pernambuco–UFPE were used to evaluate antifungal activity.
The Sabouraud Dextrose Agar (SDA) solid medium, prepared according to the manufacturer’s
instructions, and the doubly concentrated Sabouraud Dextrose Broth (SDB) liquid medium, purchased
from HIMEDIA®, were used. The Potato Dextrose Agar (PDA) medium, purchased from Difco®,
depleted by dilution and added to agar was used for the fungal morphology analysis. The media were
solubilized with distilled water and autoclaved at 121 ◦C for 15 min.
All strains were initially kept in refrigerated (8 ◦C) slanted SDA at the Cariri Applied Mycology
Laboratory-LMAC of the Regional University of Cariri-URCA. For microdilution assays, strains were
initially cultivated on SDA media at 37 ◦C for 24 h. Cell suspensions were then prepared in tubes
containing 4 mL of sterile saline solution (0.9% NaCl) and their turbidity was compared and adjusted
according to the MacFarland 0.5 scale [43].
Dimethyl sulfoxide (DMSO-Vetec) was used for the dilution of the extracts and the antifungal
fluconazole 150 mg (prati-donaduzzi), diluted in water, was used as the commercial drug reference in
the tests. For the initial extract solution preparations, 0.15 g were weighed and solubilized in 1 mL of
DMSO. The extracts and fluconazole were then further diluted in sterile distilled water to obtain the
desired test concentration (16,384 µg/mL).
4.4.2. IC50 Determination and Cell Viability Curve
This assay was performed using the broth microdilution technique in 96-well plates. Each well
was filled with the medium and inoculum, followed by the extracts and fluconazole, before being
individually microdiluted (81,92 to 8 µg/mL). The last well was reserved as a growth control, all tests
were performed in quadruplicate [44], with changes in concentration. Natural product and fluconazole
dilution controls (with 0.9% sodium chloride solution instead of inoculum) and sterility controls were
also performed. The plates were incubated at 37 ◦C for 24 h, then read on an ELISA spectrophotometer
(Kasuaki-DR-200Bs-BI) at a wavelength of 450 nm. Results from the absorbance were used to construct
the cell viability curve; from the mean cell viability curve, the IC50 values of the extracts and fluconazole
were calculated [45].
4.4.3. Minimum Fungicidal Concentration (MFC) Determination
For this test, a sterile rod was introduced into each well of the microdilution test plate (except for
the sterility control), where after homogenization of the medium contained in the well, a petri dish
with SDA was sub-cultured by transferring a small aliquot of the test solution (medium + inoculum +
natural product). The plates were incubated at 37 ◦C for 24 h and checked for Candida colony growth or
lack thereof [46], with modifications. The MFC was defined as the lowest natural product concentration
capable of inhibiting the growth of fungal colonies.
4.4.4. Evaluation of the Modifying Effect of Fluconazole Action
The combination of the extracts with the reference drug (fluconazole) was performed to verify
whether the antifungal action was modified by the presence of the extract in the medium. Solutions
containing the extracts were tested at a sub-inhibitory concentration (MFC/16), according to the
methodology used by [47], with changes in concentrations. If the extracts potentiated the action
of the antifungal, the observed effect was considered to be synergistic; however, if it impaired its
action, it was considered to be an antagonistic effect. Fluconazole was microdiluted at a 1:1 proportion
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up to the penultimate well. Sterility controls were also performed. All tests were performed in
quadruplicate. The plates were incubated at 37 ◦C for 24 h. The readings were performed in an ELISA
spectrophotometry device (Kasuaki-DR-200Bs-BI) [45].
4.4.5. Effect of the Extracts and Fluconazole on Candida Morphological Transition
Microculture chambers were used to verify changes in fungal morphology by the extracts
and fluconazole through the reduction or prevention of hyphae development. The extracts and
fluconazole were individually evaluated at different concentrations (HCE-8192 µg/mL, HCE/4-2048
µg/mL, and HCE/16-512 µg/mL, where HCE is the highest concentration evaluated by microdilution).
The tests were performed according to [48,49], with modifications: Two parallel striae were made in
the solid medium (PDA), which were subsequently covered with a sterile cover slip. For comparative
purposes, growth controls as well as fluconazole antifungal controls were performed. The chambers
were incubated for 24 h (37 ◦C), inspected, and recorded by an optical microscope (AXIO IMAGER
M2-3525001980-ZEISS-Germany) using a 20X objective. The Zen 2.0 software was used to measure
hyphae and pseudohyphae extensions, where images were taken from each complete stria, with five
random images being selected from these, according to the concentration. The values were used for
statistical analysis [50].
4.5. Statistical Analysis
A two-way ANOVA was applied to each sample, comparing the values for each extract
concentration, with Bonferroni’s post hoc test, in which p < 0.05 and p < 0.0001 were considered
significant while p > 0.05 was not significant. IC50 values were obtained by nonlinear regression with
unknown interpolation of standard curves obtained from fungal growth values as a function of the
extract concentration, expressed in µg/mL. Statistical analysis was performed using the Graphpad
Prism software, version 6.0.
Measurement of the complete striae borders, as well as of the regions where hyphal growth was
observed, was performed for virulence analysis. Then, measurements of all hyphal filaments identified
in five randomly selected regions from each striae and concentration were performed. Hyphal filament
length was averaged and analyzed by ANOVA followed by Bonferroni’s correction for multiple
comparisons according to the product concentration [50].
5. Conclusions
Preliminary phytochemical analysis of the extracts detected the presence of phenolic and flavonoid
compounds in both extracts. The activity of the extracts against the tested strains was not clinically
relevant since direct contact growth inhibition only began at high concentrations. In the fluconazole
modulatory assay, the extracts presented synergistic effects with some concentrations. The natural
product inhibited hyphal and pseudohyphal growth in the fungal morphological transition assay,
depending on the tested concentrations.
Studies on the modulatory and morphological activity of S. tuberosa extracts are rare, with the
present study being the first to report on these activities, as well as to report on the analysis of S. tuberosa
extracts by high performance liquid chromatography. Thus, research addressing the mechanisms of
action of these extracts and the bioactivity of their chemical constituents is necessary to better explore
the pharmacological potential of the species.
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